USPTO serial 88514109
AIDAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 2, 2021
- Examiner
- PAYABYAB, EDWARD TAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AIDAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pikesville, MD, US
COLUMBIA, MD, US
Pikesville, MD, US
Pikesville, MD, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andy I. Corea
Andy I. Corea MURTHA CULLINA185 ASYLUM STREETHARTFORD, CT 06103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical care, clinical research and clinical trials, namely, clinical data and regulatory submission management on behalf of medical, data analytics, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data and patient reported subjective and objective data for business purposes; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Services consisting of the registration, collection, transcription, compilation and systemization of written communications and data; Health care cost containment services; health care utilization management and review services; medical cost management | ACTIVE | Jul 3, 2019 |
| 042 | Disease management as a service (DMaaS) services, namely, providing a website featuring technology for use by others to analyze disease progression prediction and for medical status assessment; Software as a service (SaaS) services, namely, hosting and managing software for use by others for use for overall health assessment; Data as a service (DaaS) services featuring software for use to determine effective drugs, therapies and medications; Behavior Change as a service (BCaaS) services in the nature of software as a service (Saas) featuring software for facilitating behavior science backed coaching and training for use by others for behavior modification and healthy lifestyle modification; Platform as a service (PaaS) featuring computer software platforms for the collection, processing, storage and exchange of human health and disease data; Platform as a service (PaaS) featuring computer software platforms to derive insights and understanding about human health and disease; Platform as a service (PaaS) featuring computer software platforms for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for medical status assessment and making medical decisions; Platform as a service (PaaS) featuring computer software platforms for determining effective therapies and medications; Platform as a service (PaaS) featuring computer software platforms for providing behavior therapy; providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research services in the fields of blood, breath, and saliva analysis and health care monitoring; breath and saliva biochemical analysis services; biological research; biomedical research; laboratory research in the field of biochemistry, biology, health and medicine; providing a web site featuring on-line non-downloadable software that enables patients, physicians, insurers, biopharmaceuticals and other healthcare providers to generate, evaluate, manage and exchange medical information; Providing temporary use of on-line non-downloadable software and applications for communications between patients, payers, biopharmaceuticals, caregivers, contract research organizations, and health care providers in conducting health assessments, health coaching, preventative health measures, condition management, and making informed health decisions; Providing temporary use of on-line non-downloadable software for collecting patient and care giver health information and facilitating communications between patients, payers, biopharmaceuticals, caregivers, contract research organizations, and health care providers, and predicting, recording, reporting, transmitting, tracking and monitoring patient real-time vital health information | ACTIVE | Jul 3, 2019 |
| 044 | Health care services, namely, providing a database in the field of disease detection, therapy and management information for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Health care services, namely, behavioral therapy for an individual or group of individuals for medical diagnosis, management, and treatment purposes; Providing wellness and disease management programs; behavioral health counseling services, namely, programs in the field of behavioral change to promote wellness and disease management; mental health care counseling services; personal health assessments, namely, personal assessments of health risk, fitness, nutrition and lifestyle; providing smoking cessation and weight loss program services; managed health care services, including, health and wellness counseling services; disease care management services; nursing services; medical care home care services, namely, providing personalized and customized health and wellness assessment, health care, disease management, medical treatment and wellness plans and programs; medical care services, namely, providing personalized and customized advice and recommendations on home health treatment and care programs, providing assistance in transitioning patients from hospital to home, and evaluating and monitoring a patient's condition; providing on-line health care and health information relating to health coaching services; Medical evaluation services, namely, assessment of patients undergoing medical treatment; medical diagnostic monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; maintaining patient medical records and files; medical counseling; medical screening; medical testing for diagnostic or treatment purposes; Dietitian services; Nutrition counseling; Dietary and nutritional guidance; Disease management as a service (DMaaS) services, namely, providing medical analytics and healthcare services all for use by others for use for disease progression prediction and for medical status assessment | ACTIVE | Jul 3, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Multisensor Diagnostics, LLC
- Other trademarks owned by AIDAR HEALTH, INC.
- Other trademarks owned by Multisensor Diagnostics, LLC
- Other trademarks owned by Multisensor Diagnostics, LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AIDAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 2, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 31, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 30, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 13, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 12, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 30, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 28, 2020 | IUAF | USE AMENDMENT FILED | — |
| Oct 28, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 28, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 28, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 28, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 28, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 29, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 28, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 28, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 28, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 28, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 21, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 21, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 21, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2019 | NWAP | NEW APPLICATION ENTERED | — |